X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (60802) 60802
Newsletter (11581) 11581
Newspaper Article (10420) 10420
Publication (6806) 6806
Book Review (1136) 1136
Magazine Article (792) 792
Trade Publication Article (633) 633
Book Chapter (602) 602
Report (449) 449
Transcript (259) 259
Book / eBook (239) 239
Government Document (227) 227
Conference Proceeding (212) 212
Dissertation (121) 121
Web Resource (43) 43
Reference (20) 20
Data Set (15) 15
Paper (8) 8
Streaming Video (4) 4
Journal / eJournal (3) 3
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
vaccines (44116) 44116
humans (35580) 35580
index medicus (31015) 31015
immunology (21000) 21000
animals (20212) 20212
vaccination (18209) 18209
female (17501) 17501
immunization (13669) 13669
male (12057) 12057
medical research (12039) 12039
research (12021) 12021
vaccine (10977) 10977
health aspects (10253) 10253
clinical trials (10230) 10230
cancer (9704) 9704
infectious diseases (9615) 9615
medicine, research & experimental (9524) 9524
antigens (9385) 9385
immunotherapy (9016) 9016
medicine, experimental (8569) 8569
mice (8517) 8517
adult (8043) 8043
infections (7980) 7980
prevention (7722) 7722
infection (7421) 7421
immunogenicity (6953) 6953
care and treatment (6782) 6782
analysis (6754) 6754
efficacy (6732) 6732
influenza (6587) 6587
viruses (6426) 6426
proteins (6264) 6264
children (5806) 5806
cancer vaccines (5587) 5587
middle aged (5586) 5586
studies (5552) 5552
adolescent (5445) 5445
immune response (5338) 5338
infant (5238) 5238
antibodies (5140) 5140
public health (5120) 5120
child (5071) 5071
microbiology (5015) 5015
allergy and immunology (4843) 4843
medicine (4788) 4788
immunity (4755) 4755
disease (4576) 4576
dendritic cells (4504) 4504
oncology (4468) 4468
child, preschool (4406) 4406
research article (4387) 4387
veterinary sciences (4310) 4310
safety (4297) 4297
t cells (4289) 4289
influenza vaccines (4148) 4148
pharmaceutical industry (4101) 4101
product development (4083) 4083
article (4075) 4075
aged (4042) 4042
immune system (4010) 4010
hiv (3907) 3907
epidemiology (3839) 3839
virology (3821) 3821
mortality (3698) 3698
aids vaccines (3539) 3539
immune-responses (3383) 3383
biotechnology & applied microbiology (3377) 3377
malaria (3362) 3362
drug therapy (3224) 3224
multidisciplinary sciences (3214) 3214
lymphocytes (3208) 3208
mice, inbred balb c (3153) 3153
virus diseases (3148) 3148
treatment outcome (3071) 3071
young adult (3041) 3041
human papillomavirus (2985) 2985
tuberculosis (2922) 2922
antibodies, viral - blood (2913) 2913
risk factors (2892) 2892
pediatrics (2891) 2891
age (2877) 2877
clinical trials as topic (2855) 2855
medicine, general & internal (2841) 2841
science (2825) 2825
infants (2815) 2815
protection (2796) 2796
pharmacology & pharmacy (2780) 2780
tumors (2689) 2689
cervical cancer (2668) 2668
human immunodeficiency virus--hiv (2627) 2627
influenza, human - prevention & control (2607) 2607
usage (2539) 2539
enzyme-linked immunosorbent assay (2516) 2516
peptides (2493) 2493
immunoglobulins (2420) 2420
biology (2397) 2397
cancer vaccines - immunology (2386) 2386
deoxyribonucleic acid--dna (2352) 2352
united-states (2342) 2342
influenza vaccines - immunology (2299) 2299
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (120) 120
Online Resources - Online (25) 25
Collection Dvlpm't (Acquisitions) - Closed Orders (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
UofT at Mississauga - Stacks (7) 7
Robarts - Stacks (5) 5
UofT at Scarborough - Stacks (5) 5
UTL at Downsview - May be requested (4) 4
Engineering & Comp. Sci. - Stacks (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Processing (1) 1
Mt Sinai Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trinity College (John W Graham) - Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (85087) 85087
French (228) 228
German (160) 160
Spanish (101) 101
Japanese (100) 100
Russian (58) 58
Chinese (42) 42
Korean (37) 37
Polish (26) 26
Italian (22) 22
Portuguese (21) 21
Turkish (8) 8
Arabic (5) 5
Danish (5) 5
Dutch (5) 5
Czech (3) 3
Hungarian (2) 2
Swedish (2) 2
Bulgarian (1) 1
Croatian (1) 1
Norwegian (1) 1
Persian (1) 1
Slovenian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 14, pp. 1275 - 1286
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 22, pp. 2083 - 2092
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e53629
The RV144 clinical trial of a prime/boost immunizing regimen using recombinant canary pox (ALVAC-HIV) and two gp120 proteins (AIDSVAX B and E) was previously... 
V1/V2 DOMAIN | POTENT | MULTIDISCIPLINARY SCIENCES | REGIONS | IMMUNODEFICIENCY-VIRUS TYPE-1 | CHEMOKINE RECEPTOR | HIV-1-INFECTED INDIVIDUALS | INFECTION | GP120 | MONOCLONAL-ANTIBODIES | QUATERNARY NEUTRALIZING EPITOPE | Protein Structure, Tertiary | Amino Acid Sequence | Humans | AIDS Vaccines - immunology | Models, Molecular | Molecular Sequence Data | Peptides, Cyclic - immunology | Antibodies, Viral - blood | Peptides, Cyclic - chemistry | AIDS Vaccines - chemistry | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV-1 - immunology | Peptide Fragments - chemistry | Immunization, Secondary | Peptide Fragments - immunology | Antibodies, Viral - immunology | HIV Envelope Protein gp120 - chemistry | Infection | Proteins | Medical research | AIDS vaccines | Analysis | Clinical trials | Medicine, Experimental | Product development | HIV (Viruses) | Health aspects | Plasma | Peptides | Risk | Infections | Biochemistry | Vaccines | Assaying | Multivariate analysis | Subgroups | Variables | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Armed forces | Fusion protein | Dissection | Drug dosages | Public health | Recombinant | Immunization | Immunoglobulins | Departments | Effectiveness | Health risks | Pharmacology | Epitopes | Medicine | Studies | Disease prevention | Pathology | Infectious diseases | Glycoprotein gp120 | Cancer | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2013, Volume 8, Issue 9, p. e75665
Neutralizing and non-neutralizing antibodies to linear epitopes on HIV-1 envelope glycoproteins have potential to mediate antiviral effector functions that... 
DEPENDENT CELLULAR CYTOTOXICITY | RECOMBINANT GLYCOPROTEIN-120 VACCINE | CONFORMATIONAL EPITOPE | NEUTRALIZING ANTIBODIES | BROAD NEUTRALIZATION | CD4 BINDING-SITE | MULTIDISCIPLINARY SCIENCES | ENVELOPE PROTEIN | HUMAN-IMMUNODEFICIENCY-VIRUS | HUMAN MONOCLONAL-ANTIBODIES | TRANSMEMBRANE PROTEIN | HIV Antibodies - blood | HIV Envelope Protein gp120 - genetics | HIV Infections - prevention & control | Immunoglobulin G - blood | HIV Envelope Protein gp41 - immunology | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Risk | Case-Control Studies | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - immunology | Immunoglobulin G - immunology | HIV Infections - blood | Amino Acid Sequence | HIV-1 - genetics | Antigens, Viral - immunology | HIV-1 - immunology | Sequence Alignment | B-Lymphocytes - immunology | Immunoglobulin A - immunology | Antibodies, Neutralizing - blood | Medical research | Medical colleges | AIDS vaccines | Peptides | Immunoglobulin G | Clinical trials | Glycoproteins | HIV (Viruses) | Risk factors | Infection | Medicine, Experimental | Health aspects | Antigenic determinants | Correlation | Laboratories | Antibodies | Viruses | Cytotoxicity | Biology | Infections | Vaccines | Immunoglobulin A | Human immunodeficiency virus--HIV | Public health | Recombinant | Antigens | Immunoglobulins | Immune response | Effectiveness | Glycoprotein gp41 | Research & development--R&D | Health risks | Risk reduction | Epitopes | Biophysics | Glycoprotein gp160 | Infectious diseases | Lymphocytes B | Neutralizing | Glycoprotein gp120 | Cancer | Research & development | R&D | HIV | Human immunodeficiency virus
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2012, Volume 12, Issue 7, pp. 531 - 537
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2019, Volume 381, Issue 20, pp. 1897 - 1908
A candidate vaccine against smallpox, modified vaccinia Ankara, was studied in 440 participants. MVA elicited immune responses similar to those associated with... 
RESPONSES | ACAM2000 | MEDICINE, GENERAL & INTERNAL | IMMUNOGENICITY | VIRUS | PROTECTION | SAFETY | DRYVAX(R) | ANTIBODY | MVA | COMPLICATIONS
Journal Article